0001209191-19-013268.txt : 20190225 0001209191-19-013268.hdr.sgml : 20190225 20190225200024 ACCESSION NUMBER: 0001209191-19-013268 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190221 FILED AS OF DATE: 20190225 DATE AS OF CHANGE: 20190225 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SLATTERY JOSEPH P CENTRAL INDEX KEY: 0001246530 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19437 FILM NUMBER: 19631267 MAIL ADDRESS: STREET 1: C/O TRANSENTERIX, INC. STREET 2: 635 DAVIS DRIVE, SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSENTERIX INC. CENTRAL INDEX KEY: 0000876378 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112962080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-765-8400 MAIL ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: SafeStitch Medical, Inc. DATE OF NAME CHANGE: 20080211 FORMER COMPANY: FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC DATE OF NAME CHANGE: 19930328 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-21 0 0000876378 TRANSENTERIX INC. TRXC 0001246530 SLATTERY JOSEPH P C/O TRANSENTERIX, INC. 635 DAVIS DRIVE, SUITE 300 MORRISVILLE NC 27560 0 1 0 0 EVP and CFO Common Stock 2019-02-21 4 S 0 17650 3.25 D 44929 D Common Stock 2019-02-22 4 M 0 26292 1.39 A 71221 D Common Stock 2019-02-22 4 S 0 71221 3.25 D 0 D Common Stock 25000 I By IRA Stock Option 1.39 2019-02-22 4 M 0 26292 0.00 D 2028-02-07 Common Stock 26292 774708 D The transactions occurred pursuant to a written trading plan dated November 29, 2017, meeting the requirements of Rule 10b5-1(c) with these sales hitting an established sales price trigger of $3.25 per share. Following the sales on February 21, 2019 and February 22, 2019, the reporting person continues to beneficially own 25,000 shares of the company's common stock. The reporting person also holds stock options to acquire 2,448,178 shares of common stock, of which approximately 31% are vested, and restricted stock units representing an additional 931,999 shares of common stock subject to forfeiture restrictions. Vests 25% on the first anniversary of the date of grant and 1/48th of the entire award monthly on the vesting date anniversary for 36 months, subject to acceleration as set forth in the Incentive Plan and the reporting person's Employment Agreement with the Company. /s/ Joshua Weingard, as Attorney-in-Fact for Joseph Slattery 2019-02-25